01
BeyondImpact
Where Science Meets Strategy in Longevity
BeyondImpact is a forward-thinking consultancy that partners with clinics, biotech companies, and healthcare providers to shape the future of longevity care. We focus on strategic execution, clinical delivery models, and translational research, helping our partners implement cutting-edge science into practice.
Why BeyondImpact Matters
The longevity sector is advancing at breakneck speed, but clear and strategic guidance is rare. Clinics, investors, biotech companies, and consumer brands are eager to lead. Many struggle to:​​
✻​
Distinguish validated science from marketing hype
✻​
Identify interventions with true clinical value
✻​
Build credibility and trust in a noisy, fast-moving market
​​​BeyondImpact helps bridge this gap by turning cutting-edge research into actionable strategies and scalable impact.
How BeyondImpact Works
Our consultancy operates at the intersection of science, market intelligence, and strategic execution. We help clients across the longevity ecosystem to:​
✻​
Translate validated longevity science into clinical protocols and consumer products
✻​
Design credibility pathways for novel interventions
✻​
Navigate regulatory and market challenges with expert insight
✻​
Build trusted brands that resonate with both clinicians and consumers
Why Choose BeyondImpact
Scientific Depth: We bring expertise from leading longevity researchers and clinical practitioners.
Cross-Sector Insight: Our team connects biotech, clinical medicine, consumer health, and investment perspectives.
Credibility First: We focus on building science-backed pathways to market, not short-term hype.
Tailored Engagements: Every client is unique. We design strategies aligned to your vision and stage of growth.
At BeyondImpact, we do more than advise. We help build the future of longevity by advancing credible innovations that matter.
02
BeyondClock
The Next Generation Biological Clock—Finally Understandable, Truly Actionable
BeyondClock redefines how we measure and manage aging. Moving beyond the noise of unreliable epigenetic clock tests, it uses clinically trusted biomarkers to deliver biological age insights that are precise, explainable, and actionable. Built on advanced clinical aging models by longevity pioneers Dr. Brian Kennedy and Dr. Jan Gruber, BeyondClock empowers healthcare providers to track aging and guide personalized interventions with clarity and confidence.
Why BeyondClock Matters
For years, epigenetic clocks promised to decode biological age—but failed to deliver clinical value. These Direct-to-Consumer epigenetic tests fluctuate wildly, lack clear medical guidance, and are often just research tools in disguise. BeyondClock changes that.
​
It uses over 60 routine lab test markers—already familiar to doctors and patients—to produce a biological age score that:​
✻​
Correlates with real-world healthspan and mortality
✻​
Responds meaningfully to interventions like caloric restriction
✻​
Offers clear guidance for clinical action
​No special tubes. No DNA sequencing. Just science that works in the clinic.
How BeyondClock Works
The BeyondClock system is powered by LinAge2, a clinically validated aging clock that:
✻​
BeyondClock outperforms most leading biological clocks across all critical metrics
✻​
Uses principal component analysis to decode the key drivers of aging
✻​
Connects each age score with traceable, treatable biomarkers
All inputs are derived from standard blood panels, making BeyondClock:
✻​
Fast (results in <24 hrs)
✻​
Cost-effective (insurance-covered in many cases)
✻​
Clinically reliable (CV <5%)
Why Clinicians Choose BeyondClock
No new protocols needed: works with standard lab workflows
​
Reliable, high-quality results: biomarkers are CLIA/FDA-validated
​
Actionable insights: each biological age component can be traced to specific clinical drivers
Scientific Performance
In comparative studies:
✻
BeyondClock outperforms GrimAge, PhenoAge, and Horvath clocks on all critical metrics
✻
Captured a 2.4-year drop in biological age in the CALERIE caloric restriction trial—missed by methylation clocks
Backed by peer-reviewed studies in NPJ Aging and Nature Aging, BeyondClock is setting a new clinical standard.
​
Built for Longevity Clinics. Ready for Real Life.
​
If you're a medical leader or health system builder, BeyondClock offers the tool your practice has been waiting for:
✻ Clinically intuitive
✻ Cost-efficient
✻ Scientifically superior
03
BeyondInsight
Clarity in Complexity. Structure in Motion
Independent evaluation for the frontier of human longevity. BeyondInsight offers expert-led validation and strategic analysis for those shaping the future of healthspan science—investors, institutions, and innovators seeking substance over speculation.
Why BeyondInsight Matters
The Promise of Longevity Is Real. The Noise Is Louder. The longevity field is accelerating, but alignment is missing:
✻​
Aging is not yet a disease — so what qualifies as a treatment?
✻​
Biomarkers remain unstandardized, and often unproven.
✻​
Regulatory and clinical translation pathways are unclear.
We help you cut through this — calmly, critically, and credibly.
BeyondInsight Perspective
The longevity field brims with potential, but progress is hindered by fragmented research, unproven biomarkers, and unclear regulatory pathways. Most consulting firms offer surface-level analysis—we go deeper.
​
BeyondInsight provides independent, expert-led validation to separate credible science from speculation. We help investors, innovators, and institutions:
✻​
Evaluate mechanisms with biological plausibility
How BeyondInsight Works
Scientific Validation
✻​
Mechanism of action analysis
✻​
Experimental integrity and reproducibility
✻​
Translational feasibility and biological rationale
Market Intelligence
✻​
Sector and competitive mapping
✻​
Commercial viability and investment outlook
✻​
Regulatory and policy environment
Strategic Guidance
✻​
Implementation blueprints and scenario planning
✻​
Resourcing and milestone tracking
✻​
Risk frameworks and scaling strategy
Expert Network
✻​
Global access to scientific and policy leaders in academic, biotech, pharma, AI, space health, and regulatory science
Why Choose BeyondInsight
This Is Not a Diligence Checklist.
​
This Is a Decision Framework for What Deserves to Move Forward.
​
Others offer surface scans or trend decks. BeyondInsight offers tailored, peer-reviewed, multi-dimensional evaluation.
​
Every engagement is bespoke. Every answer is earned. We are discreet. We are selective. We operate with intent.
Who BeyondInsight Support
✻​
Venture Funds & Family Offices validating early-stage technologies and late-stage positioning
✻​
Biotech & Pharma Leaders preparing for investment, trials, or partnerships
✻​
Public & Multilateral Institutions shaping long-term health policy
Space Health & Resilience Teams applying counter-aging research to extreme environments
✻​
Identify biomarkers with clinical relevance
✻​
Navigate regulatory and commercial hurdles
Our work ensures that only the most promising longevity research receives funding, development, and public trust.
Case Study
From Lab to Clinical to Market: How to Become the Next AKG or NAD+
Validating Rejuvant® — A Model for Translational Success in Longevity Science
​
In the field of longevity, Rejuvant® (Calcium Alpha-Ketoglutarate) offers a compelling example of science turned into measurable human benefit. Originally studied for its role in energy metabolism and mitochondrial support, AKG was long overlooked for its clinical potential in aging. That changed with a multi-year, multi-modal validation effort spanning preclinical trials, biological mechanism studies, and epigenetic age testing in humans.
​
Through this layered process, the product demonstrated a statistically significant reversal of biological age — up to 8 years in some individuals — as measured by DNA methylation clocks. ​
​
BeyondInsight draws inspiration from this model, not to promote a single molecule, but to create frameworks that ensure the next AKG or NAD+ is built on real science, not hype.
What Made AKG Credible: A Validation Playbook
The AKG case highlights how rigorous science can become a commercial and clinical success:​​
✻​
Mechanism of Action was biologically plausible: AKG enhances longevity in animal models, plays a role in metabolic regulation, and inflammation modulation.
✻​
Reproducibility & Safety were addressed via animal studies and long-term usage tracking.
✻​
Human Data from TruDiagnostic's epigenetic clocks quantified biological age reversal in a real-world setting.
✻​
Strategic Positioning as a supplement, not a drug, enabled faster market entry with regulatory compliance
This multi-layered approach is exactly what BeyondInsight formalizes and tailors across interventions.
Mechanistic Validity
Is the science plausible and robust?
Clinical Relevance
Do biomarkers translate into measurable health outcomes?
Strategic Fit
Is the intervention positioned for real-world use?
Market Readiness
Is the path to regulatory approval and adoption clear?
Beyond AKG: What Comes Next
At BeyondInsight, we don’t chase trends. We build the frameworks to validate what’s real, and guide what’s next. Whether it’s a novel mTOR inhibitor, a senolytic compound, or the next NAD+ analog, we ask the hard questions early — and answer them with rigor.
Our role is not to amplify hype. It’s to clarify potential:
✻​
What deserves funding?
✻​
What can scale?
✻​
What earns trust from regulators, clinicians, and the public?
This multi-layered approach is exactly what BeyondInsight formalizes and tailors across interventions.